University of Michigan researchers said Sunday they have created a line of human embryonic stem cells that will spur the state’s medical research industry. The cell line, known as UM4-6, was developed under a 2008 program approved by Michigan voters that allows the development of stem cells from unused human embryos obtained from fertility clinics.
Recent Posts
- Stem cells provide a potent treatment for frailty
- Cracking a ‘holy grail’ challenge in cancer cell therapy
- New Bio-Implant for Spinal Cord Repair
- Seattle jury awards $24M in lawsuit against stem cell center
- Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
- After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
